In squamous cell carcinomas (SCC) of the skin, in oral SCC, head and neck SCC as well as breast cancer, GRHL3 has been demonstrated to mediate tumor‐suppressive effects [6, 7, 8, 9, 10]. Here, GRHL3 is linked to neoplasm.